Holen Sie sich die Stockscreener-App
1.80
6.51%
0.11
Biorestorative Therapies Inc Aktie (BRTX) Neueste Nachrichten
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 1-Year High at $1.50 - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.65 - Defense World
BioRestorative Therapies (NASDAQ:BRTX) Shares Up 1.3% - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month High at $1.64 - MarketBeat
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Large Decline in Short Interest - Defense World
BioRestorative Therapies (OTCMKTS:BRTX) Shares Pass Below 50-Day Moving Average of $1.69 - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 12-Month High at $1.75 - MarketBeat
BioRestorative Therapies, Inc. announced that it has received $0.5 million in funding - Marketscreener.com
BioRestorative Therapies (OTCMKTS:BRTX) Share Price Crosses Below 50 Day Moving Average of $1.70 - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Forecasted to Earn Q3 2024 Earnings of ($0.36) Per Share - Defense World
BioRestorative Therapies (NASDAQ:BRTX) PT Raised to $18.00 at Roth Mkm - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q2 2024 Earnings Call Transcript - Insider Monkey
BioRestorative Therapies (NASDAQ:BRTX) Releases Earnings Results, Beats Expectations By $0.06 EPS - Defense World
Roth Capital Equities Analysts Reduce Earnings Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World
Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com India
Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - OrthoSpineNews
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update - Defense World
Head-To-Head Review: BioRestorative Therapies (OTCMKTS:BRTX) vs. Arno Therapeutics (OTCMKTS:ARNI) - Defense World
BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Tuesday - Defense World
BioRestorative Therapies to Report Second Quarter 2024 - GlobeNewswire
BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 - Yahoo Finance
BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.66 - Defense World
BioRestorative Therapies’ Chief Scientist Named New Section - GlobeNewswire
BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine - StockTitan
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Decline in Short Interest - Defense World
Taking a look at what insiders are doing to gauge the BioRestorative Therapies Inc (BRTX)'s direction – Knox Daily - Knox Daily
Technical analysis of BioRestorative Therapies Inc (BRTX) stock chart patterns – US Post News - US Post News
Analyzing Ratios: BioRestorative Therapies Inc (BRTX)'s Financial Story Unveiled – DWinneX - The Dwinnex
BioRestorative Therapies maintains $15 target on Japan patent news - Investing.com
BioRestorative Therapies maintains $15 target on Japan patent news By Investing.com - Investing.com UK
BioRestorative Therapies Announces Notice of Allowance for - GlobeNewswire
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem ... - StockTitan
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week High at $2.20 - Defense World
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - Yahoo Finance
Investing in BioRestorative Therapies Inc (BRTX): What You Must Know – Knox Daily - Knox Daily
Bullish BioRestorative Therapies, Inc. (NASDAQ:BRTX) insiders filled their treasuries with US$593k worth of stock over ... - Yahoo New Zealand News
Check out these key findings about BioRestorative Therapies Inc (BRTX) – Sete News - SETE News
Market Recap Check: BioRestorative Therapies Inc (BRTX)'s Negative Finish at 2.03, Up/Down -8.56 – DWinneX - The Dwinnex
The Attractiveness of Investing In BioRestorative Therapies Inc (BRTX) is Growing – Knox Daily - Knox Daily
Promising Developments in Waldenstrom Macroglobulinemia Treatment: Mustang Bio's Latest Clinical Trial Results ... - BP Journal
BioRestorative Therapies regains compliance, reports Q1 2024 results - MSN
What's Going On With BioRestorative Therapies Stock? - MSN
BRTXBioRestorative Therapies, Inc. Latest Stock News & Market Updates - StockTitan
What's Going On With BioRestorative Therapies Stock?BioRestorative Therapies (NASDAQ:BRTX) - Benzinga
Q2 2024 EPS Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) Cut by Analyst - Defense World
What was BioRestorative Therapies Inc (BRTX)'s performance in the last session? – US Post News - US Post News
BioRestorative Therapies regains compliance, reports Q1 2024 results - Seeking Alpha
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 ... - GlobeNewswire
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 ... - Yahoo Finance
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results - Yahoo Finance
Enerplus (NYSE:ERF) Now Covered by Analysts at StockNews.com - Defense World
Roth Capital Brokers Cut Earnings Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World
Buying Buzz: BioRestorative Therapies Inc [BRTX] VP of Research and Development Silva Francisco purchases 6600 ... - Knox Daily
BioRestorative in discussions for potential license agreement for ThermoStemTipRanks.com - TipRanks
Should New Investors Buy Penny Stocks? - PennyStocks
BioRestorative Therapies (NASDAQ: BRTX) Advances in Regenerative Medicine with ThermoStem® Licensing Talks - BP Journal
Are the recent gains on Longeveron Inc (NASDAQ: LGVN) sustainable ? - BP Journal
Company’s Banking Shares: Up -75.18% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
S&P 500 Edges Higher; J.Jill Shares PlungeSignet Jewelers (NYSE:SIG) - Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day ... - Benzinga
Gold Down 1%; Broadcom Shares Jump After Upbeat ResultsBroadcom (NASDAQ:AVGO) - Benzinga
Shares of Biotech MicroCap Rip on Licensing Talks - The Globe and Mail
Why BioRestorative Therapies Stock Is Moving Higher Thursday - Benzinga
1.25%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):